Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Intangibles (2017 - 2025)

Marimed has reported Intangibles over the past 9 years, most recently at $17.2 million for Q4 2025.

  • Quarterly Intangibles fell 7.67% to $17.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.2 million through Dec 2025, down 7.67% year-over-year, with the annual reading at $17.2 million for FY2025, 7.67% down from the prior year.
  • Intangibles was $17.2 million for Q4 2025 at Marimed, down from $18.0 million in the prior quarter.
  • Over five years, Intangibles peaked at $21.7 million in Q1 2025 and troughed at $162000.0 in Q4 2021.
  • The 5-year median for Intangibles is $17.1 million (2023), against an average of $13.3 million.
  • Year-over-year, Intangibles crashed 92.73% in 2021 and then surged 8666.05% in 2022.
  • A 5-year view of Intangibles shows it stood at $162000.0 in 2021, then surged by 8666.05% to $14.2 million in 2022, then increased by 19.79% to $17.0 million in 2023, then rose by 9.56% to $18.6 million in 2024, then dropped by 7.67% to $17.2 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Intangibles are $17.2 million (Q4 2025), $18.0 million (Q3 2025), and $20.7 million (Q2 2025).